Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...

Food and Drug Administration (FDA) Commissioner Marty Makary said in an interview with Politico’s Dasha Burns that the FDA ...

The FDA is still on track to meet its user fee targets despite a higher-than-normal vacancy rate among scientific reviewers.

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...

Empower Pharmacy, a Houston-based compounding pharmacy, has been sanctioned by the FDA and other states in the past decade.

The recall has been given a Class II classification, indicating there is a significant level of risk posed to consumers in ...

Food and Drug Administration Commissioner Marty Makary said in a recent interview he has no plans to change policies ...

The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...

The '80s were a time of unique food products and diet trends, but these eyebrow-raising food safety issues just weren't top ...

Sarepta Therapeutics (SRPT) stock drops as the company faces potential FDA-mandated studies after safety concerns over its ...

Experts on the panel shared many of the same views around SSRIs, arguing the risks of the drugs during pregnancy are greater ...